Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

Oxytocin

Pitocin, Syntocinon

Quick Stats
Studies 93
Trials 100
Score 2
2025 pubmed

Metformin Attenuates Spontaneous and Stimulated Myometrium Contractions in Rat Uterine Strips.

Pehlivanoğlu. Bilge B; Tuncer. Meltem M; Doğan. Murat M

Key Findings

  • Metformin reduced the amplitude and frequency of spontaneous uterine contractions.
  • Metformin lowered contractions caused by oxytocin and carbachol, comparable to M2‑receptor blockade.
  • Combining metformin with an M3‑receptor blocker gave the strongest inhibition, suggesting synergy.

Practical Outcomes

  • For people using metformin, especially women of child‑bearing age, the drug may lower uterine activity, which could be beneficial for fertility and preventing preterm labor. However, it might also impede necessary uterine contractions during labor, so caution is advised if pregnancy is planned or near term.

Summary

Researchers found that metformin, a common diabetes drug, weakens both natural and oxytocin‑triggered uterine muscle contractions in rat tissue. The effect was similar to blocking certain muscle receptors and could help prevent early labor, but might slow needed contractions near delivery.

Abstract

Metformin, an adenosine monophosphate activated protein kinase activator, is indicated in pregnant and non-pregnant women for glucose dysregulation-associated conditions. Its role in various smooth muscle functions was documented. As the myometrium, crucial in fertility and pregnancy, is overlooked, the aim was to investigate the modulation of spontaneous and stimulated myometrium contractions by metformin. The uterus of the adult female Sprague-Dawley rats (N=15) was excised and 4 full thickness myometrium strips (2 × 10 mm) were sectioned. The strips (n=57) were challenged with KCl (80 mM) to confirm viability and determine the reference maximum response. The spontaneous contractions and dose- response curves for oxytocin (10-11-10-4M) and carbachol (CCh, 10-8-10-4M) were recorded. Additionally, CCh-induced curves were re-obtained in M2-muscarinic receptor blocker, methoctramine (10-5M) and M3-muscarinic receptor blocker, and 4-diphenylacetoxy-N-methylpiperidine (4-DAMP) (10-7M) exposed strips. The responses were obtained alone or in combination with metformin (10-4M). Metformin attenuated both the amplitude and frequency of spontaneous contractions (P < .005) as well as those stimulated by oxytocin and CCh (P < .005). This effect was comparable to M2-receptor blockage, whereas the most potent inhibition was with M3-receptor blocker and/or combinations involving it. The 90% inhibition of contraction in metformin, 4-DAMP, and methoctramine exposed strips suggests a synergistic action. Metformin may be beneficial in conditions favorable to fertilization, implantation, and prevention of preterm labor by reducing myometrial contractility during pregnancy and in non-pregnant indications. However, use of metformin should be approached with caution when strong myometrium contractions are required near term or postpartum.

Study Information

Provider

pubmed

Year

2025

Date

2025-10-30T00:00:00.000Z

DOI

10.5152/eurasianjmed.2025.250630

References

34